IHH Healthcare Berhad (SGX:Q0F)

IHH Healthcare Berhad Income Statement

Financials in millions MYR. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Operating Revenue	25,854	24,383	20,935	17,989	17,132	13,405
Other Revenue	-	-	-	-	86.06	-
Revenue	25,854	24,383	20,935	17,989	17,218	13,405
Revenue Growth (YoY)	12.49%	16.47%	16.38%	4.48%	28.45%	-10.11%
Cost of Revenue	17,282	16,061	13,870	11,817	11,219	9,298
Gross Profit	8,572	8,322	7,065	6,172	5,999	4,107
Selling, General & Admin	132	123	113	87.96	80.65	66.92
Amortization of Goodwill & Intangibles	50	53	48	49.51	47.25	56.38
Other Operating Expenses	2,615	2,572	1,192	1,862	1,394	1,158
Operating Expenses	4,720	4,492	2,915	3,394	2,870	2,683
Operating Income	3,853	3,831	4,150	2,777	3,128	1,424
Interest Expense	-1,030	-787	-688	-471.66	-444.56	-466.46
Interest & Investment Income	168	107	87	77.59	49.08	69.14
Earnings From Equity Investments	30	29	26	38.87	39.86	18.39
Currency Exchange Gain (Loss)	6	142	-194	-144.19	-604.97	-436.77
Other Non Operating Income (Expenses)	391	229	658	455.77	455.48	129.44
EBT Excluding Unusual Items	3,418	3,551	4,039	2,734	2,623	737.92
Merger & Restructuring Charges	-0.5	-0.5	-	-	-1.27	-6.32
Impairment of Goodwill	-	-	-	-150.07	-	-396.51
Gain (Loss) on Sale of Investments	6	6	2	0.99	0.93	-0.09
Gain (Loss) on Sale of Assets	-	-	-	-	14.98	10.02
Asset Writedown	180	200	8	-367.56	-82.19	-1.31
Other Unusual Items	40	-	-	-	-	223.8
Pretax Income	3,643	3,756	4,049	2,217	2,556	567.51
Income Tax Expense	824	594	658	571.95	379.15	361.66
Earnings From Continuing Operations	2,819	3,162	3,391	1,645	2,177	205.85
Minority Interest in Earnings	-514	-505	-439	-96.74	-314.06	83.04
Net Income	2,305	2,657	2,952	1,548	1,863	288.88
Preferred Dividends & Other Adjustments	-	-	-	52.21	88.3	89.84
Net Income to Common	2,305	2,657	2,952	1,496	1,774	199.04
Net Income Growth	-13.12%	-9.99%	90.65%	-16.87%	544.74%	-47.62%
Shares Outstanding (Basic)	8,822	8,808	8,807	8,803	8,782	8,776
Shares Outstanding (Diluted)	8,825	8,811	8,807	8,804	8,783	8,779
Shares Change (YoY)	0.18%	0.04%	0.03%	0.25%	0.04%	0.05%
EPS (Basic)	0.26	0.30	0.34	0.17	0.20	0.02
EPS (Diluted)	0.26	0.30	0.34	0.17	0.20	0.02
EPS Growth	-13.23%	-10.02%	97.28%	-15.89%	790.65%	-57.05%
Free Cash Flow	1,508	1,156	1,888	1,999	2,504	1,571
Free Cash Flow Per Share	0.17	0.13	0.21	0.23	0.28	0.18
Dividend Per Share	0.105	0.100	0.090	0.070	0.060	0.040
Dividend Growth	5.00%	11.11%	28.57%	16.67%	50.00%	-
Gross Margin	33.16%	34.13%	33.75%	34.31%	34.84%	30.64%
Operating Margin	14.90%	15.71%	19.82%	15.44%	18.17%	10.63%
Profit Margin	8.91%	10.90%	14.10%	8.32%	10.30%	1.49%
Free Cash Flow Margin	5.83%	4.74%	9.02%	11.11%	14.55%	11.72%
EBITDA	5,296	5,124	5,270	3,817	4,124	2,433
EBITDA Margin	20.48%	21.01%	25.17%	21.22%	23.95%	18.15%
D&A For EBITDA	1,443	1,293	1,120	1,040	995.92	1,009
EBIT	3,853	3,831	4,150	2,777	3,128	1,424
EBIT Margin	14.90%	15.71%	19.82%	15.44%	18.17%	10.63%
Effective Tax Rate	22.62%	15.82%	16.25%	25.80%	14.84%	63.73%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.